AAAAAA

   
Results: 1-12 |
Results: 12
RELATIVE BIOAVAILABILITY OF NEORAL VERSUS SANDIMMUNE IN THE PRESENCE OF A P450IIIA AND P-GLYCOPROTEIN INHIBITOR
Authors: CHOC MG MUELLER EA ROBINSON WT KUMLE A SMITH HT CHARNICK SB
Citation: Mg. Choc et al., RELATIVE BIOAVAILABILITY OF NEORAL VERSUS SANDIMMUNE IN THE PRESENCE OF A P450IIIA AND P-GLYCOPROTEIN INHIBITOR, Transplantation proceedings, 30(5), 1998, pp. 1664-1665
EQUIVALENCE OF CYCLOSPORINE BLOOD LEVEL ASSAYS IN PATIENTS RECEIVING CYCLOSPORINE MICROEMULSION OR CYCLOSPORINE
Authors: PESCOVITZ MD WONG RL CHOC MG CHANG CT
Citation: Md. Pescovitz et al., EQUIVALENCE OF CYCLOSPORINE BLOOD LEVEL ASSAYS IN PATIENTS RECEIVING CYCLOSPORINE MICROEMULSION OR CYCLOSPORINE, Clinical transplantation, 11(5), 1997, pp. 442-445
SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE - 2-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS - A REPORT OFTHE NEORAL STUDY-GROUP
Authors: PESCOVITZ MD BARONE G CHOC MG HRICIK DE HWANG DS JIN JHJ KLEIN JB MARSH CL MIN DI POLLAK R PRUETT TL STINSON JB THOMPSON JS VAZQUES E WAID T WOMBOLT DG WONG RL
Citation: Md. Pescovitz et al., SAFETY AND TOLERABILITY OF CYCLOSPORINE MICROEMULSION VERSUS CYCLOSPORINE - 2-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS - A REPORT OFTHE NEORAL STUDY-GROUP, Transplantation, 63(5), 1997, pp. 778-780
PHARMACOKINETICS OF AN ORAL SOLUTION OF THE MICROEMULSION FORMULATIONOF CYCLOSPORINE IN MAINTENANCE PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
Authors: DUNN S COONEY G SOMMERAUER J LINDSAY C MCDIARMID S WONG RL CHANG CT SMITH HT CHOC MG
Citation: S. Dunn et al., PHARMACOKINETICS OF AN ORAL SOLUTION OF THE MICROEMULSION FORMULATIONOF CYCLOSPORINE IN MAINTENANCE PEDIATRIC LIVER-TRANSPLANT RECIPIENTS, Transplantation, 63(12), 1997, pp. 1762-1767
BIOAVAILABILITY AND PHARMACOKINETICS OF CYCLOSPORINE FORMULATIONS - NEORAL(R) VS SANDIMMUNE(R)
Authors: CHOC MG
Citation: Mg. Choc, BIOAVAILABILITY AND PHARMACOKINETICS OF CYCLOSPORINE FORMULATIONS - NEORAL(R) VS SANDIMMUNE(R), International journal of dermatology, 36, 1997, pp. 1-6
SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 28(4), 1996, pp. 2183-2186
USE OF NEORAL IN PEDIATRIC RENAL-TRANSPLANTATION
Authors: ETTENGER RE SMITH HT KAISER B COONEY GF SUMMERAUER J ALEXANDER S MOULTON LT CHOC MG WONG RL
Citation: Re. Ettenger et al., USE OF NEORAL IN PEDIATRIC RENAL-TRANSPLANTATION, Transplantation proceedings, 28(4), 1996, pp. 2257-2258
THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G CHANG CT CHOC MG KLEIN JB MARSH CL MELIGENI JA MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 875-880
THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS
Authors: BARONE G BUNKE CM CHOC MG HRICIK DE JIN JHJ KLEIN JB MARSH CL MIN DI PESCOVITZ MD POLLAK R PRUETT TL STINSON JB THOMPSON JS VASQUEZ E WAID T WOMBOLT DG WONG RL
Citation: G. Barone et al., THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS, Transplantation, 61(6), 1996, pp. 968-970
ABBREVIATED PHARMACOKINETIC (PK) PROFILES IN AREA-UNDER-THE-CURVE (AUC) MONITORING OF CYCLOSPORINE (CSA) THERAPY IN DE-NOVO RENAL-TRANSPLANT PATIENTS
Authors: MARSH C PRUETT T MIN D THOMPSON J WAID CT BUNKE CM KLEIN JB PESCOVITZ MD POLLAK R VASQUEZ E BARONE G WOMBOLT D STINSON J WONG R CHOC MG HWANG DS CHANG CT
Citation: C. Marsh et al., ABBREVIATED PHARMACOKINETIC (PK) PROFILES IN AREA-UNDER-THE-CURVE (AUC) MONITORING OF CYCLOSPORINE (CSA) THERAPY IN DE-NOVO RENAL-TRANSPLANT PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1103-1103
APPLICATION ISSUES IN BIOANALYTICAL METHOD VALIDATION, SAMPLE ANALYSIS AND DATA REPORTING
Authors: DADGAR D BURNETT PE CHOC MG GALLICANO K HOOPER JW
Citation: D. Dadgar et al., APPLICATION ISSUES IN BIOANALYTICAL METHOD VALIDATION, SAMPLE ANALYSIS AND DATA REPORTING, Journal of pharmaceutical and biomedical analysis, 13(2), 1995, pp. 89-97
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF FLUVASTATIN IN HUMAN PLASMA
Authors: KALAFSKY G SMITH HT CHOC MG
Citation: G. Kalafsky et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF FLUVASTATIN IN HUMAN PLASMA, Journal of chromatography. Biomedical applications, 614(2), 1993, pp. 307-313
Risultati: 1-12 |